Journal Pre-proof Greeny Erich Evan Novel coronavirus disease 2019 (COVID-18) pandemic: considerations for the biomedical waste sector in India ‘Shobhana Ramieke, Bharat Lal Sahu Pll: '$2666-0164(20)30027-X Dol: https:/doi.org/10.1016)j.cscee.2020.100029 Reference: CSCEE 100029 To appear in: Case Studies in Chemical and Environmental Engineering Received Date: 25 May 2020 Revised Date: 21 July 2020 Accepted Date: 25 July 2020 Please cite this article as: S, Ramteke, B.L. Sahu, Novel coronavirus disease 2019 (COVID-19) pandemic: considerations for the biomedical waste sector in India, Case Studies in Chemical and Environmental Engineering, https://doi.org/10.10161).cscee.2020. 100028. This is a PDF file of an article that has undergone enhancements after acceptance, such as the addition of a cover page and metadata, and formatting for readability, but itis not yet the definitive version of record. This version will undergo additional copyediting, typesetting and review before it is published in its final form, but we are providing this version to give early visibility of the article. Please note that, during the production process, errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain. 1020 The Author(s). Published by Elsevier Ltd.Novel coronavirus disease 2019 (COVID-19) pandemic: considerations for the biomedical waste sector in India Shobhana Ramteke™, Bharat Lal Sahu? ' school of Studies in Environmental Science, Pt. Ravishankar Shukla University, Raipur-492010, CG, India ‘Corresponding author: E-mail: shubrmtk21/@ gmail.com *Department of Chemistry, Guru Ghasidas Vishwavidyalaya (A Central University), Bilaspur-495009, CG, India Abstract In late December 2019, the world woke to a truth of a pandemic of Coronavirus Disease (COVID-19), inspired by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS- CoV-2), which has a place with a gathering of beta-coronavirus. As of July 21 India is still fighting to survive against the SARS-CoV-2 as called coronavirus disease. The contaminations, first constrained in the Kerala state, have inevitably spread to every single other area, The possibility to cause dangerous respiratory disappointment and quick transmission puts COVID-19 in the rundown of the Publie Health Emergeney of International Concem (PHEIC). There is a flow overall break out of the novel coronavirus Covid-19, which started from Wuhan in China and has now spread to more than 212 countries including 14,7: ,034 cases, as of 12:20 AM on Tuly 21, 2020. Governments are feeling the squeeze to prevent the outbreak from spiralling into a worldwide wellbeing crisis. At this stage, readiness, straightforwardness, and sharing of data are vital to hazard evaluations and starting explosion control exercises. Since the episode of serious intense respiratory disorder (SARS) ises (SARS1-CoVs) have 18 years back, an enormous number of SARS-related coronavii been found in their regular repository have, bats, During this epidemic condition, expulsion of biomedical waste created from crisis facilities treating COVID-19 patients in like manner demands unprecedented thought as they can be potential bearers of the disease SARS-CoV-2, This article discusses the potential consequences of the COVID-19 pandemic on biomedical waste administrations, concentrating on basic focuses where option working methodology or extra moderation measures might be fitting, Keywords: COVID-19, coronavirus, SARS-Co-2 virus, biomedical waste.1. Introduction A third of the global population is on coronavirus lockdown, as of May, 2020. Another coronavirus malady, formally named COVID-19 by the World Health Organization (WHO), has caused a worldwide pandemic with significant changes in numerous parts of human life. On 11 February 2020, the International Committee on Taxonomy of Viruses declared serious intense respiratory disorder coronavirus (SARS-CoV-2) as the name of the new infection [1]. The main instance of the novel coronavirus was accounted for on December 30, 2019, in Wuhan city, 2 Hubei regions, PR. China. Quick moves were made by the Centre for Disease Control and Prevention (CDC), Chinese wellbeing specialists, and analysts. The WHO briefly named these pathogen 2019 novel coronavirus (2019-nCoV) [2]. During December 2019, a novel Beta-coronavirus temporarily named 2019 novel coronavirus (2019-nCoV), and along these lines authoritatively renamed extreme intense respiratory disorder coronavirus 2 (SARS-CoV-2) by the Intemational Committee on Taxonomy of Viruses (ICTV), causing coronavirus ailment 2019 (or COVID-19), was related with a group of respiratory tract diseases in Wuhan, Hubei Province, China and has quickly spread across main land’s [3] The family Coronaviridae incorporates a wide range of creatures and human infections, all portrayed by an unmistakable morphology. Virions are encompassed and round (coronaviruses) or plate, kidney, or pole molded (toroviruses). Every molecule is encircled by a periphery or "crown" speaking to the bulbous distal parts of the bargains glycoproteins [4]. In India, the principal research centre affirmed instance of COVID-19 was accounted for from Kerala on January 30, 2020. As of July 21, 2020, an aggregate of 11,118,206 confirmed eases, 700,087 recovered eases and 27,497 passing were accounted for in India, As per data available on various websites regarding COVID-19 infections worldwide, the eases are increasing exponentially. On July 21, 2020, there were 14,753,034 reported cases, which included 610,868 deaths and 8,805,686 recovered cases. From that point forward, the whole world has been found napping by the clueless increment in the number of new cases because of the exponential increment in the pace of transmission of 2019-nCoV, presently formally alluded to as SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus-2) by the International Committee on Taxonomy of Viruses, the causative operator of COVID-19 [5] Additionally, 2019-nCoV showed halfway similarity with SARS-CoV and MERS-CoV, in phylogenetic examination, clinical signs and path intelligent discoveries. Logical advances Pe ue Pe Pee ee ae sae oa dee died ee de Geigy one Gee ge‘The WHO authoritatively named the sickness ‘COVID-19', The International Committee on Taxonomy of Viruses named the infection ‘serious intense respiratory disorder coronavirus 2° (SARS-CoV-2). Assignment of a conventional name for the novel coronavirus and the ailment it caused is helpful for correspondence in clinical and logical research, This infection has a place ith the B-coronavirus family an enormous class of pervasive infections. Like different infections, SARS-CoV-2 has numerous potential common hosts, middle of the road hosts and last has [7]. Specialists sequenced the genome of new infection and made sense of 86.9% of the genome is equivalent to the SARS-CoV genome. Subsequently the name was changed to Severe Acute Respiratory Syndrome Corona Virus-2 (SARS-CoV-2) [8] COVID-19 is decently irresistible with a generally high death rate, yet the data accessible out in the open reports and distributed writing is quickly expanding. The point of this survey is, to sum up, the ebb and flow comprehension of COVID-19 including causative operator, pathogenesis of the malady, determination, and treatment of the eases, just as control and counteraction methodologies. As the biggest known RNA infections, CoVs are additionally isolated into four genera: alpha-coronavirus, beta-coronavirus, gamma-coronavirus and delta~ coronavirus. Until this point, there have been six human coronaviruses (HCoVs) distinguished, including the alpha-CoVs HCoVs-NL63 and HCoVs-229E and the beta-CoVs HCoVs-OC43, HCoVs-HKU Middle Fast respiratory disorder CoV (MERS-CoV). Coronaviruses have caused two . Serious intense respiratory condition CoV (SARS-CoV) and enormous scope pandemies in the previous two decades, SARS and Middle East respiratory disorder (MERS). It has for the most part been imagined that SARSr-CoV which is primarily found in bats could cause a future infection episode [9] 2. Morphology, structure and possible transmission routes of SARS-CoV-2 COVID-19 is an ittesistible sickness brought about by a novel coronavirus. The COVID-19 pandemic is the third major zoonotic coronavirus sickness episode in just two decades, following the SARS (Severe Acute Respiratory Syndrome) outbreak in 2002-2003 and the MERS (Middle East Respiratory Syndrome) outbreak in 2012. The sickness was first answered to the WHO by Chinese Health Officials on 31 December 2019 as atypical ov pneumonia of obscure reason [10,11]. The infection is hereditarily like the SARS coronavirus and is in like manner expected to 35 have crossed the species obstruetion fiom creature to human [12,13]. Even though its particular starting points are yet to be resolved,protein, The envelope bears club formed glycoprotein projections and some coronaviruses likewise contain a fixed agglutinin-esterase protein (HE), The viral genome contains particular highlights, including a novel N-terminal section inside the spike protein [14-16]. Genes for the major structural proteins in all coronaviruses occur in the 5’-3" order as S, E, M, and N (Figure 1). The transmission behavior of SARS-CoV-2 also has important implications for waste and wastewater services. SARS-CoV-2 specifically targets host cells containing ACE2 proteins. ACE2 is an enzyme attached to the outer surface (cell membranes) of cells in the lungs, arteries, heart, kidney and intestines. After infecting and exhausting all resources in the host cell to multiply, the viruses leave the cell in a process known as shedding. Data from clinical and virological studies provide evidence that shedding of the SARS-CoV-2 virus is most significant early in the course of the disease, immediately before and within a few days since onset of symptoms [1]. 3. Replication process of SARS-CoV-2 SARS-CoV-2 (COVID-19) ties to ACE2 (the angiotensin-changing over compound 2) by its Spike and permits COVID-19 to go into the cell and taint cells. All together for the infection to finish section into the cell following this underlying procedure, the spike protein must be prepared by a compound called a protease. Comparable on account of SARS-CoV, SARS- CoV-2 (COVID-19) utilizes a protease called TMPRSS? to finish this procedure. To append an infection receptor (spike protein) to its cell ligand (ACE2), actuation by TMPRSS2 as a protease is required [17]. The infection enters into the respiratory tract and ties with the receptor and the infection goes into the host cell the genome is deciphered and afterward interpreted. Coronavirus genome replication and interpretation happens at cytoplasmic layers and includes facilitated procedures of both nonstop and intermittent RNA amalgamation that are intervened by the viral repeat, a colossal protein complex encoded by the 20-kb replicase quality. The proteins are amassed at the cell layer and genomic RNA is joined as the develop molecule shapes by growing from the inward cell films [18]. The COVID-19 is required to get destructive through human to human transmissions because of hereditary bottlenecks for RNA infections regularly happen during respiratory bead transmissions (Figure 2) 4. Implications for biomedical wasteby social insurance foundations, inquire about offices, and research centres including minor or dispersed sources, for example, treatment is taken at home for example insulin infusion [19]. WHO detailed that genuine wounds are much of the time brought about by contact with combustible, destructive or receptive synthetic compounds in clinical waste. A WHO report guaranteed that in the year 2000, 21 million individuals were tainted with Hepatitis B, 2 million individuals with Hepatitis C and 260,000 individuals with HIV on the planet because of polluted needle stick wound [20]. WHO expresses that 85% of hospital ws tes are really non-hazardous, though 10% are infectious and 5% are non-infectious yet they are remembered for hazardous wastes. About 15% to 35% of hospital waste is directed as infectious waste. India roughly produces 2 kw/bed/day and this biomedical waste envelops wastes like an anatomical waste, cytotoxic waste, sharps, which when insufficiently isolated could cause various types of fatal invesistible ailments and furthermore cause interruptions in the earth, and antagonistic effect on biological parity. Around 600 g for each day per bed in a general professional's facility/E.g. 100 had relations with the clinic will ereate unsafe/infectious waste at the pace of 5 to 10 kg/day [21]. As indicated by the Ministry of Environment and Forest (MoEF) net age of BMW in India is 4,05,702 kg/day, out of which just 2,91,983 kg/day is disposed, which implies that practically 28% of the wastes is left untreated and not disposed to diseover its way in dumps or water bodies and re-enters our framework. In India around 30% of the total injections administered every year were finished utilizing reused or inappropriately sanitized clinical gear, and around 10% of medicinal services establishments offer these pre-owned syringes to the waste pickers. An exploration demonstrated that the population which lives inside 3kms good ways from old incinerators saw an expansion of hazard is contracting malignant growth by 3.5%. BMW is classified into different categories and each category has its own methods of disposal [22] (Figure 3). Removal of biomedical waste produced from emergeney clinies treating COVID-19 patients likewise requests extraordinary consideration as they can be potential bearers of the infection SARS-CoV2. Sanitation labourers and cloth pickers are in danger from dealing with plain clinical waste rising out of homes where COVID-19 patients are isolated, clinical specialists, and waste administration masters cautioned. Disposed of covers, gloves and tissues could be potential hotspots for the spread of this profoundly infectious ink Most emergency clinics follow the Biomedical Waste Management (BMWM) Rules 2016 tion.with this waste identified with COVID-19, be it masks, gloves, the hazardous materials suit. This waste could taint cloth pickers, kids, or the poor living in the city. It is additionally essential to guarantee that this waste doesn't arrive at regular dumping grounds. The tale coronavirus gets transmitted through direet touch and tainted surfaces and items, as per an administration report on the utilization of personal protective equipment (PPE). Sanitary staff associated with cleaning now and again contacted surfaces and cloths are at moderate hazard and should utilize N-95 masks and gloves. Biomedical waste management in India BMW (management and handling) rules 1998, figured by the Ministry of Environment and Forests, Government of India (GOI) came into power on 28 July 1998, The standards applied to each one of the individuals who created, gathered, got, put away, arranged, treated and took care of BMW in any wa ‘These standards had been proclaimed as an authoritative obligation of all social insuraee foundations. Under the Environment Protection Act 1986, these BMW have been sorted into 10 classifications with the end goal of safe removal According to BMW rules 2011, these classes were additionally changed to eight for simpler I The principles further explained the meaning of BMW in this way including immunization removal by human services labourers. Then after, BMW rules 2016 were presented [ camps, blood gift camps, carefial camps or social insurance exercises undertaken outside the medicinal services office. It visualized the health care facilities (HCF) to make an arrangement inside their premises for a protected, ventilated and made sure about the area for capacity of isolated biomedical waste. It further states pre-treatment of the research centre and microbiological squander, blood tests and sacks through purification on location in the way as recommended by WHO or National AIDS Control Organization (NACO) rules and afterward sent to the normal biomedical waste treatment office for definite removal Strikingly, it eliminates utilization of chlorinated plastic sacks, gloves and blood packs two years from the date of notice of these principles. It further features the significance of preparing and inoculation of social insurance labourers. It further proclaims the foundation of a standardized identification framework for the removal of BMW (Figure 4). The most punetual revealing of both major and minor mishaps has likewise been given due importance. Considering the treatment and removal of BMW, the human services offices are coordinated to abstain from developing nearby office if such office is accessible inside 75 km separation.6. Crises for handlings of BMW during coronavirus pandemic Recently, Delhi and Mumbai are the two most affected cities from coronavirus in India. In Delhi, more than 40 sanitation workers have tried positive for the infection, and 15 have lost their lives. In Mumbai, 10 workers and two security monitors at the city’s two landfills, in Deonar and Kanjurmarg, have been contaminated with COVID-19 and recouped. These are simply figures from two of the most influenced cities in the nation today. India is near the very edge of a COVID-induced waste crisis, and the specialists know about it. Likewise, used masks, tissties, head covers, shoe covers, expendable material outfits, non-plastic, and semi- plastic coveralls were to be discarded in a yellow pack implied for incineration at a common biomedical waste treatment facility (CBWTF). So were extra food, expendable plates, alasses, utilized covers, tissues, and toiletries of COVID-19 patients, The nation has 200 biomedical waste treatment offices; these two are in Delhi and one is in Mumbai. Furthermore, as per CPCB information, these offices are as of now running at 60% limit — that is a 15% bounce since March. The national average is low in light of the fact that numerous cases have not flooded in numerous urban communities, the manner in which they have in Dethi and Mumbai. In these two cities, the CBWTFs are running at 70-75% and 70% limits, as indicated by CPCB and the Maharashtra Pollution Control Board respectively. Before the COVID-19 episode, an administration or a private emergency clinie would ordinarily deliver $00 g of biomedical waste (like needles, pee packs, dressing, and so on) per bed, every day. Presently, that number has gone up to between 2.5 to 4 kg per bed, daily, according to SMS Water Grace BMW Private Limited, one of the two CBWTFs in Delhi, which gathers squander from labs, isolate focuses, and emergency clinics, including one of the city's COVID-19 government offices, the Lok Nayak Jai Prakash Narayan Hospital. An enormous COVID-19 office can anyplace between 1800 to 2200 kg of biomedical waste every day. Presently duplicate this with the quantity of Covid-19 emergency clinics in the nation: 2,900, Add to it the biomedical waste created from 20,700 quarantine centres, 1,540 sample collection centres, and 260 laboratories managing the COVID-19 pandemie, and the biomedical waste gathered by regions (Delhi alone has 12,000 home isolation facilities) and one gets a feeling of the sheer volume of the issue. Delhi creates 27 tons of non-COVID biomedical waste and as much as 11 tons of COVID-19 related waste each da as per the CPCB; Mumbai has been producing 9 tons of COVID-19 waste and 6 tons of non-COVID biomedical waste each day, BMC (Brihanmumbai Municipal Corporation) estimates.scientists wamed, Not simply Delhi and Mumbai, the expansion in biomedical waste is stressing authorities in Kerala as well. Two months after the state began dealing with COVID biomedical waste dependent on revised CPCB rules, Kerala has rewarded in exeess of 100 tons of waste from COVID-care centres. During the peak of the emergeney, Wuhan, the city where the flare-up started, created 240 tons per day of clinical decline — six times the ordinary level, as per the nation’s Environment Ministry. Manila in the Philippines delivered an extra 280 tons per day of clinical waste, while Jakarta produced 212 tons, the Asian Development Bank evaluated. By April, 50 tons of infectious waste were accumulating every day in Thailand's clinical focuses, which just had the ability to adequately bum 43 tons, as indicated by the Thailand Environment Institute In Wuhan, the irregularity was far and away more terrible, with just 49 tons of limit for each day to manage almost multiple times the degree of debased waste during the peak of disease, 7. Guidelines for handlings of BMW by the Central Pollution Control Board (CPCB) Recently, India produces around 600 metric tons of biomedical waste daily, which is approximately 10% more wastes, due to this pandemie situation of COVID-19 (Figure 6). With COVID waste being produced at a quicker pace and high volume, it is all the more testing to see that it is arranged without causing extra medical issues. It is evaluated that overall, 2 tons of COVID waste is created in each state from analyses, isolate and treatment of the illness. This is excessively low contrasted with the 240 tons of waste created each day in Wuhan, the focal point of the pandemic [25] A set of guidelines on dealing with, treatment, and removal of waste produced during treatment, determination and isolation of COVID-19 patients was released by the Central Pollution Control Board, New Delhi, Government of India on Mareh 18, 2020. Under these, isolation wards in hospitals need to keep up discrete shading coded canisters for the isolation of waste. A committed container marked 'COVID-19', should have been kept in a different, brief extra space and should just be taken care of by approved staff. The separate arrangement of sanitation labourers in these wards for biomedical waste administration was likewise suggested. The board also requested a record of the waste produced in segregation wards. For isolate camps and home consideration of the presumed patients, the CPCB instructed assortment concerning biomedical waste in yellow packs and the canisters containing these ought to be given over to approve authorities (Figure 7). The guidelines suggest that those8. Conclusion In the condition of the COVID-19 scourge, this article shows that huge research is expected to evaluate the business as usual for plague mindfulness and reaction in the biomedical squanders. We require exposing the discussion around potential changes to rehearse, for example, for the assortment and treatment of biomedical waste materials from emergency clinics and isolate offices with positive or suspected COVID-19 patients, Current relief practices, for example, the utilization of retaining times may do a lot to decrease the dangers to labourers taking care of strong squanders, yet extra amendments to systems might be required and ought to be thought of. Here is likewise a squeezing requirement for information on SARS-CoV-2 pervasiveness and determination in biomedical waste to all the more likely comprehends related transm ion pathways and to illuminate proper hazard the board activities for the biomedical part, Further examination into a conceivable airborne transmission of COVID-19 is likewise justified, as exercises from past episodes including SARS-CoV demonstrated that this pathway was a factor in sickness spread. At long last, the capacity to distinguish SARS-CoV-2 in bio medical waste gives a perfect chance to return to its benefits as an information source. Albeit singular protection contemplations and a need to guarantee information security can be a test, given the scale, human cost and monetary effect of COVID-19, this exploration ought to continue with earnestness. 8. Reference 1 Nghiem, L.D., B. Morgan, E. Donner, and M.D. Short, The COVID-19 pandemic: considerations for the waste and wastewater services sector. Case Studies in Chemical and Environmental Engineering, 2020: p. 100006. di 10.1016/j.cseee.2020. 100006. 2 ul Qamar, M-T., S.M. Algahtani, M.A. Alamri, and L.L. Chen, Structural basis of SARS-CoV-2 3CLpro and ami-COVID-19 drug discovery from medicinal plants. Journal of Pharmaceutical Analysis, 2020. doi: 10.1016/j,jpha.2020.03.009. Lupia, T., S. Scabini, S. Momese Pinna, G. Di Perti, F.G. De Rosa, and S. Corcione, 2019 novel coronavirus (2019-nCoV) outbreak: A new challenge. Jounal of Global Antimicrobial Resistance, 2020. 21: p. 22-27. doi: 10.1016/j,jgar.2020.02.021. 4, Burrell, C.J., C.R. Howard, and F.A. Murphy, Chapter 13 - Coronaviruses. Fenner White’s Medical Virology, 2017: p. 437-446. doi: 10.1016/B978-0-12-375156- 0.00031-X. 5. Al-Qahtani, A.A. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV- 2): Emergence, History, Basie and Clinical Aspects. Saudi Jounal Biological10. Ml 12 1B 18, 19. Wang, L,Y. Wang, D. Ye, and Q. Liu, Review of the 2019 novel coronavirus (SARS-CoV-2) based on current evidence. International Journal of Antimicrobial Agents, 2020: p. 105948. doi: 10.1016) ijantimicag.2020.105948. Naserghandi, A., S.F. Allameh, and R. Saffarpour, Al! about COVID-19 in brief. New Microbes = New Infections, 2020. 35: p. 100678. doi: 10.1016/j.nmni.2020. 100678. Wu, D., T. Wu, Q Liu, and Z. Yang, The SARS-CoV-2 outbreak: What we know: Intemational Jounal of Infectious Diseases, 2020. 94: p. 44-48. doi 10.10164}ijid.2020.03.004 Taylor, D.B., A Timeline of the Coronavirus Pandemic, in New York Times. 2020, Poon, L.L.M. and M. Peiris, Emergence of a novel human coronavirus threatening suman health, Nature Medicine, 2020, 26(3): p. 317-319. Gorbalenya, A.E., S.C. Baker, RS. Barie, RJ. de Groot, C. Drosten, A.A. Gulyaeva, BLL, Haagmans, C. Lauber, A.M. Leontovieh, B.W. Neuman, D. Penzar, S. Perlman, LLM. Poon, D.V. Samborskiy, LA. Sidorov, I Sola, J. Ziebubr, and V. Coronaviridae Study Group of the International Committee on Taxonomy of, The species Severe acute respiratory syndrome-related coronavirus: classifying 2019- nCoV and naming it SARS-CoV-2. Nature Microbiology, 2020. (4): p. 536-544. Cheng, V.C.C,, S.K-P. Lau, P.C.Y. Woo, and K.Y. Yuen, Severe Aeute Respiratory Syndrome Coronavirus as an Agent of Emerging and Reemerging Infection. Clinical Microbiology Reviews, 2007. 204): p. 660. World Health Organization, Naming the coronavirus disease (COVID-19) and the virus that causes it, Geneva: WHO, 2020. World Health Organization, Coronavirus disease 2019 (COVID-19) Situation Report-40. WHO; 2020 Available from: https://www.who.int/does/default-source! coronaviruse/situation-reports/20200229-sitrep-40-covid19. paf?sfirsn=849d0665_2, accessed on February 29, 2020. Indian Council of Medical Research, Revised Strategy of COVID19 Testing in India (Version 3, dated 20/03/2020), New Delhi: ICMR; 2020. Available from https://iomr.nic.in/sites/defaultfiles/upload_documents/2020-03-20 covid19 _test_v3.pdf, accessed on March 30, 2020. WHO hitps://www.wwho int/emergencies/diseases/novel-coronavirus-2019 (2020) Accessed date: 17 April 2020. Zhang, Q., Jiang, X., Tong, D., Davis, $.1., Zhao, H.,Geng,G., and R. Ni, Transboundary health impacts of transported global air pollution and international trade, Nature, 2017. $43: 705-709. Status of Biomedical Waste Management in National Capital Territory of Delhi Available at: hitp://www.medwasteind.org/pdf’. Accessed on 15 May 2016. World Health Organization, Safe Healthcare Waste Management, Policy Paper Department of Protection of the Human Environment Water, Sanitation and Health Available at htp:/www, ‘who.int/immunization_safety/publications/waste_management/en’safe health care_23, 24. Environment: Case Study of Pune India, 1OSR Journal of Applied Chemistry (IOSR- JAC), 2014. 6(6): 21-27. Major changes proposed in the Bio-Medical Waste Management Rules, 2016 and its likely implication. Available at: _—_http://pibphoto.nic.in/documents/ link/2016/mar/p201632701 pdf. Accessed on 15 May 2016. Bio-Medical Waste Management Rules, 2016. Available al: hitp:/nabh.co/Announcement/ BMW Rules 2016.pdf. Accessed on 15 May 2016. Central Pollution Control Board (CPCB), Guidelines for handling, treatment and disposal of waste generated during treatment/diagnosis/quarantine of COVID-19 patients. 2020. New Delhi, Central Pollution Control Board, Govt. of India Declaration of interests The authors declare no conflict of interest.Graphical Abstract Figure. 1 | Representation of the structure of Coronavirus Figure. | Representation of COVID-19 with the cellular attachment fuctor ACE2 and antigen infection of lung cells, Figure3 | Categories of BMW. Figure. 4 | Elements and consecutive steps of the biomedical waste management plan. Figure. 5 | Biomedical Waste Management Rules 2016. Figure. 6 | Generation of BMW (in metric tons per day) in India [25], (Statist, 2020), Figure. 7 | Guidelines by the CPCB for the biomedical waste management. Figure 8 | Safety equipment for the biomedical laborer by the CPCB guidelines Graphical Abstract Waste generation Sorting at hospital Waste collection Disposal process Human ‘anatomy waste | NI Landfiling Sharps waste —> Pr2hrs j S wait petore Incineration collection i “ae + OOS Source Ieparation issuspended| | Adhocservices =p with increasing. collection frequency With Covid-19 Autoclaving wardsFigure 2© 1.General (70.6%) © 2 infectious agents (10.21%) 3. harps (9.939%) Chemical & Pharmaceutical (8.43%) © 5, Pathological agents (0.77%) © 6. Radioactive (0.0650) ( Biomedical Waste ) — { Biomedical waste minimisation/separation } at ( Biomedical waste identification (labelling) at ( Biomedical waste handling at {Schedule for collection within the health care premises at ( Selection of storage area till on-site treatment tT ( Biomedical waste treatment (On-site/off-site) ( Ss Biomedical waste disposal ) at ( Record/report Jeee ene cee) eee ied cone enue) ‘Scalpels, Blades, Needles Syringes with fixed needle Sharp metals, Needle tip cutter Perrine fee ee aris eMac eee lay tae ee +d Figure 5 350 Treatment and disposal in metrictons per day Ge SRE EFigure 6 an Using Covid-19 Shouldonty cae separate double labelled be ina colour-coded ian a handled by separate, re ccllection colour-coded authorised ‘temporary oe bags bins staff storage colour) room Figure 7ournal Pre- Figure 8